Sony Biotechnology Inc. Sony Biotechnology Inc.cart
About Us Products What's New Library News Calendar Contact Us Place Order
Safety Data Sheet (SDS) PE Anti-mouse CD84 Antibody     Product Data Sheet (PDF)    
PE Anti-mouse CD84 Antibody
1214025 50 µg $95.00       
1214030 200 µg $260.00       
Clone: mCD84.7
Isotype: Armenian Hamster IgG
Reactivity: Mouse
Immunogen: Mouse CD84-Fc fusion protein
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

FC - Quality tested

Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Application References: 1. Romero X, et al. 2005. J. Immunol. 174:7033.
C57BL/6 mouse splenocytes stained with

C57BL/6 mouse splenocytes stained with mCD84.7 PE

Description: CD84 is a 64-82 kD glycoprotein. It is a member of the SLAM (CD150) family, a CD2 subset of the Ig superfamily, also known as SLAMF5 or Ly9b. CD84 is expressed on B cells, monocytes, thymocytes, subset of T cells, and platelets. CD84 functions as a homophilic adhesion molecule and enhances T cell activation and cytokine production.
Other Names: GR6, Ly9b, SLAMF5
Structure: 64-82 kD glycoprotein, SLAM family, CD2 subset of Ig superfamily
Distribution: B cells, monocytes, thymocytes, platelets, subset of T cells
Function: Homophilic adhesion, T cell activation
Ligand Receptor: CD84
Antigen References: 1. de la Fuente MA, et al. 1997. Blood 90 (6):2398.
2. Tangye SG, et al. 2002. Eur. J. Immunol. 32(6):1640.
3. Tangye SG, et al. 2003. J. Immunol. 171:2485.
4. Martin M, et al. 2001. J. Immunol. 167:3668.
5. Romero X, et al. 2005. J. Immunol. 174:7033.